Key facts
- Notable investors include Catalyst by Wellstar, Alloy Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Polysight
- ·The full record, as it builds
Funding rounds
No funding rounds for Polysight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Polysight
Developer of an AI-powered compliance management platform designed to streamline and automate regulatory compliance for healthcare organizations. The company's platform leverages artificial intelligence to monitor regulatory changes, analyze their impact, and coordinate compliance responses in real time, reducing manual effort and administrative burden, enabling health systems, hospitals, and care teams to improve operational efficiency, reduce regulatory risk, and dedicate more resources to patient care.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2025
- Employees
- 5
- Website
- polysight.ai/
- Ownership
- Privately Held (backing)
Polysight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Polysight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Polysight in its N-PORT filings yet. We sweep new filings monthly.